Evaluating surface area reduction using MolecuLight Imaging Device
Research type
Research Study
Full title
A 12-week, single-blind, prospective, randomized, controlled, pilot clinical trial to evaluate surface area reduction with use of the MolecuLight i:X™ Imaging Device compared to standard treatment of chronic wounds
IRAS ID
229705
Contact name
Calver Pang
Contact email
Sponsor organisation
Bradford Institute for Health Research
Duration of Study in the UK
0 years, 2 months, 20 days
Research summary
This is a prospective, 12-week, single-blinded, randomized, controlled clinical trial comparing the use of an imaging device (MolecuLight) and standard treatments of chronic wounds in surface area reduction. This study is aimed to determine if the imaging device can predict non-healing wounds and/or wounds at risk of infection. It also aims to determine if MolecuLight device aids in the healing and prevention of infection in chronic wounds compared to the standard care. This is being investigated because wound care is a major clinical challenge and presents as a major burden worldwide. The study population will involve patients with chronic wounds who are registered within the vascular ulcer clinic. Many factors that impairs wound healing would be within the exclusion criteria
REC name
Wales REC 6
REC reference
17/WA/0203
Date of REC Opinion
4 Jul 2017
REC opinion
Further Information Favourable Opinion